Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Cell. Neurosci.

Sec. Cellular Neurophysiology

This article is part of the Research TopicMemory processing in health and disease: linking behavioral, circuits, and molecular scales.View all 9 articles

Personalized resilience: how individual variability in brain–immune responses to stress influences the development of anxiety disorders

Provisionally accepted
  • Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

The final, formatted version of the article will be published soon.

Stress exposure has increased significantly, contributing to higher rates of anxiety, depression, and post-traumatic stress disorder. However, individual responses to stress vary greatly, underscoring the concept of stress resilience. The acute stress response activates the amygdala, hippocampus, and prefrontal cortex, stimulating the HPA axis and triggering cortisol release, which typically restores balance through negative feedback mechanisms. In contrast, chronic stress or exposure to severe stressors leads to sustained HPA axis activation, amygdala hyperreactivity, and immune dysfunction, all of which promote the development of anxiety disorders. This review explores potential central and peripheral biomarkers of resilience, emphasizing the interplay between immune responses, the HPA axis, and the endocannabinoid signaling system. We discuss whether amygdala reactivity could serve as a predictor of stress vulnerability, along with cortisol levels and sleep disturbances, as these are often hallmarks of stress-related disorders. Furthermore, we suggest that pro-inflammatory cytokines such as TNF-α and IL-6—key indicators of stress-induced inflammation—may serve as predictors of anxiety-related vulnerability. Furthermore, we discuss the potential role of the endocannabinoid system as an integrative hub for stress responses. Given its capacity to coordinate central and peripheral mechanisms—from neuroimmune to metabolic processes—we examine how genetic and functional variations in CB1R and FAAH may influence individual resilience, highlighting their potential as biomarkers of stress susceptibility. Clinically is of utmost relevance the identification of reliable and reproducible biomarkers for advancing diagnostic precision and developing personalized therapeutic interventions for stress-related disorders.

Keywords: Amygdala reactivity, CB1R, cortisol levels, Endocannabinoid signaling system, FAAH, HPA axis, IL-6, Immune responses

Received: 13 Nov 2025; Accepted: 09 Feb 2026.

Copyright: © 2026 Peixoto and Fonseca. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Rosalina Fonseca

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.